Plasma levels of Sdc-1 and sTM in patients with or without an adverse condition. Plasma levels of Sdc-1 (A) and sTM (B) in patients with normal (n = 70) and abnormal (n = 37) GCS scores; plasma levels of Sdc-1 (C) and sTM (D) in patients with a normal (n = 60) and abnormal (n = 47) eGFR; plasma levels of Sdc-1 (E) and sTM (F) in patients without SLE (w/o SLE) (n = 43) or with SLE (w/SLE) (n = 14); plasma levels of Sdc-1 (G) and sTM (H) in patients without (no ICU) (n = 69) or with (ICU) ICU (n = 38) admission; and plasma levels of Sdc-1 (I) and sTM (J) in patients who were not intubated (no intub., n = 86) or were intubated (Intub., n = 21). A Mann-Whitney U test (2 tailed and nonparametric) was performed to determine the statistical significance. Each dot represents 1 individual patient. The horizontal bars within the dots present the median and IQR. P > .05 (n.s., not significant); **P < .01; ****P < .0001.